Myeloma Center

,

UAMS Myeloma Center Hits Impressive Milestone, Sees 1000th Article Published

,

By Nathan Tidwell

Researchers and physicians with the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) recently published their 1,000th article, an impressive milestone that demonstrates the center’s high level of scholarship.

“This is a remarkable achievement by our amazing Myeloma Center physicians and researchers,” said Frits van Rhee, M.D., Ph.D., clinical director of the Myeloma Center, part of the Winthrop P. Rockefeller Cancer Institute.

Sandy Mattox, MNSc, RN, who tracks publications for the Myeloma Center, notes that No. 1,000 was a paper published in the July 11, 2023, issue of Blood Advances titled “Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.” It was co-authored by van Rhee and UAMS physicians and researchers Samer Al Hadidi, M.D.; Carolina Schinke, M.D.; John Shaughnessy Jr., Ph.D.; Sharmila Thanendrarajan, M.D.; Mauricio Zangari M.D.; and Fenghuang (Frank) Zahn, M.D., Ph.D.

UAMS Myeloma Center Hits Impressive Milestone, Sees 1000th Article Published

,

Denver Bronco’s Defensive Tackle D.J. Jones Highlights UAMS Myeloma Center in My Cause, My Cleats Campaign

,

By Marty Trieschmann

As part of the National Football League’s (NFL) annual My Cause, My Cleats campaign, Denver Broncos defensive tackle D.J. Jones donated a pair of custom cleats to the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute.

Since 2016, participating NFL teams and players customize footwear with designs that represent causes and charities they support.

“I am honored to have this opportunity to highlight the lifesaving work of the UAMS Myeloma Center,” said Jones. “My mother-in-law, Angela Fannin, was diagnosed with multiple myeloma in 2007 and underwent a successful bone marrow transplant at UAMS.”

Fannin, 60, now living in Atlanta, is a 15-year survivor of the rare blood cancer that affects approximately 34,000 people each year.

https://news.uams.edu/2023/01/11/denver-broncos-defensive-tackle-d-j-jones-highlights-uams-myeloma-center-in-my-cause-my-cleats-campaign/

,

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

,

By Linda Haymes

The Myeloma Center at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is offering a new cutting-edge immunotherapy treatment for myeloma patients.

UAMS is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.

“This is exciting because this is the first cellular therapy product commercially available for myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D. Ph.D.

https://news.uams.edu/2021/08/09/uams-offering-revolutionary-car-t-cell-therapy-for-myeloma-patients/

,

Riney Foundation Gives $1.8 Million to UAMS Myeloma Center in the Winthrop P. Rockefeller Cancer Institute

,

By Benjamin Waldrum

May 20, 2021 | LITTLE ROCK — The Paula and Rodger Riney Foundation announced a gift of $1.8 million to the University of Arkansas for Medical Sciences (UAMS) Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research.

“Paula and I are pleased to invest in the UAMS Myeloma Center, which has made great strides in advancing multiple myeloma research and increasing survival rates,” Rodger Riney said. “As a multiple myeloma patient, I understand the critical need to pursue new research and treatments, in hopes of ultimately finding a cure.”

Rodger Riney is the former founder and CEO of the discount brokerage firm Scottrade. He was diagnosed with multiple myeloma in 2015 and has since become an advocate for research and treatment of the disease, including serving on the board of directors for the Multiple Myeloma Research Foundation.

https://news.uams.edu/2021/05/20/riney-foundation-gives-1-8-million-to-uams-myeloma-center-in-the-winthrop-p-rockefeller-cancer-institute/